Insider Trading Alert - WebMD Health Corporation And 4 Others Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Sept. 6, 2013, 132 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $13.05 to $156,271,000.00.

Highlighted Stocks Traded by Insiders:

WebMD Health Corporation (WBMD) - FREE Research Report

Wygod Martin J who is Chairman of the Board at WebMD Health Corporation sold 46,017 shares at $32.90 on Sept. 6, 2013. Following this transaction, the Chairman of the Board owned 167,685 shares meaning that the stake was reduced by 21.53% with the 46,017 share transaction.

The shares most recently traded at $33.10, up $0.20, or 0.6% since the insider transaction. Historical insider transactions for WebMD Health Corporation go as follows:

  • 4-Week # shares sold: 167,775
  • 12-Week # shares sold: 184,825
  • 24-Week # shares sold: 184,825

The average volume for WebMD Health Corporation has been 756,600 shares per day over the past 30 days. WebMD Health Corporation has a market cap of $1.7 billion and is part of the technology sector and computer software & services industry. Shares are up 130.75% year to date as of the close of trading on Friday.

WebMD Health Corp. provides health information services to consumers, physicians and other healthcare professionals, employers, and health plans through its public and private online portals, mobile platforms, and health-focused publications in the United States. Currently there are 2 analysts that rate WebMD Health Corporation a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WBMD - FREE

TheStreet Quant Ratings rates WebMD Health Corporation as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income and revenue growth. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and generally higher debt management risk. Get the full WebMD Health Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Actavis (ACT) - FREE Research Report

Michelson Jack who is Director at Actavis sold 6,064 shares at $139.54 on Sept. 6, 2013. Following this transaction, the Director owned 1,877 shares meaning that the stake was reduced by 76.36% with the 6,064 share transaction.

Wilkinson George Fred who is Pres-Global Brands&Biosimilars at Actavis sold 16,749 shares at $138.00 on Sept. 6, 2013. Following this transaction, the Pres-Global Brands&Biosimilars owned 52,469 shares meaning that the stake was reduced by 24.2% with the 16,749 share transaction.

The shares most recently traded at $137.88, down $0.12, or 0.09% since the insider transaction. Historical insider transactions for Actavis go as follows:

  • 4-Week # shares sold: 116,963
  • 12-Week # shares sold: 116,963
  • 24-Week # shares sold: 116,963

The average volume for Actavis has been 1.2 million shares per day over the past 30 days. Actavis has a market cap of $18.7 billion and is part of the health care sector and drugs industry. Shares are up 59.76% year to date as of the close of trading on Friday.

Actavis, Inc., an integrated specialty pharmaceutical company, engages in developing, manufacturing, marketing, selling, and distributing generic, branded generic, brand, biosimilar, and over-the-counter pharmaceutical products worldwide. Currently there are 12 analysts that rate Actavis a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ACT - FREE

TheStreet Quant Ratings rates Actavis as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Actavis Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Applied Materials (AMAT) - FREE Research Report

Kerley Jay who is GVP, Chief Information Officer at Applied Materials sold 562 shares at $15.59 on Sept. 6, 2013. Following this transaction, the GVP, Chief Information Officer owned 124,375 shares meaning that the stake was reduced by 0.45% with the 562 share transaction.

The shares most recently traded at $15.60, up $0.01, or 0.06% since the insider transaction. Historical insider transactions for Applied Materials go as follows:

  • 4-Week # shares sold: 75,000
  • 12-Week # shares sold: 115,758
  • 24-Week # shares sold: 255,973

The average volume for Applied Materials has been 12.2 million shares per day over the past 30 days. Applied Materials has a market cap of $18.9 billion and is part of the technology sector and electronics industry. Shares are up 35.58% year to date as of the close of trading on Friday.

Applied Materials, Inc. provides manufacturing equipment, services, and software to the semiconductor, flat panel display, solar photovoltaic (PV), and related industries worldwide. The stock currently has a dividend yield of 2.55%. Currently there are 7 analysts that rate Applied Materials a buy, 1 analyst rates it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AMAT - FREE

TheStreet Quant Ratings rates Applied Materials as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Applied Materials Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Fiserv (FISV) - FREE Research Report

Gianoni Michael P who is EVP, Group President at Fiserv sold 1,500 shares at $97.55 on Sept. 6, 2013. Following this transaction, the EVP, Group President owned 16,255 shares meaning that the stake was reduced by 8.45% with the 1,500 share transaction.

The shares most recently traded at $98.71, up $1.16, or 1.18% since the insider transaction. Historical insider transactions for Fiserv go as follows:

  • 4-Week # shares sold: 4,000
  • 12-Week # shares sold: 8,000
  • 24-Week # shares sold: 25,329

The average volume for Fiserv has been 566,700 shares per day over the past 30 days. Fiserv has a market cap of $12.7 billion and is part of the services sector and diversified services industry. Shares are up 23.62% year to date as of the close of trading on Friday.

Fiserv, Inc., together with its subsidiaries, provides financial services technology worldwide. The company has a P/E ratio of 23.1. Currently there are 8 analysts that rate Fiserv a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FISV - FREE

TheStreet Quant Ratings rates Fiserv as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Fiserv Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Energen (EGN) - FREE Research Report

Mcmanus J T who is Chairman and CEO at Energen sold 15,000 shares at $67.85 on Sept. 6, 2013. Following this transaction, the Chairman and CEO owned 106,264 shares meaning that the stake was reduced by 12.37% with the 15,000 share transaction.

The shares most recently traded at $68.48, up $0.63, or 0.92% since the insider transaction. Historical insider transactions for Energen go as follows:

  • 12-Week # shares sold: 14,594
  • 24-Week # shares sold: 15,594

The average volume for Energen has been 621,100 shares per day over the past 30 days. Energen has a market cap of $4.9 billion and is part of the basic materials sector and energy industry. Shares are up 51.21% year to date as of the close of trading on Friday.

Energen Corporation, an energy holding company, engages in the development, acquisition, exploration, and production of oil, natural gas, and natural gas liquids in the continental United States. The stock currently has a dividend yield of 0.86%. The company has a P/E ratio of 23.9. Currently there are 6 analysts that rate Energen a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EGN - FREE

TheStreet Quant Ratings rates Energen as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full Energen Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Asia Markets Fall on Latest Tariff Threats From Trump

Asia Markets Fall on Latest Tariff Threats From Trump

Google Invests in JD.com; Comcast-Disney Battle Nears Head -- ICYMI

Google Invests in JD.com; Comcast-Disney Battle Nears Head -- ICYMI

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

REPLAY: Jim Cramer on Tariff Worries, Oil, Alphabet and Centene

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Video: Athens Stock Exchange CEO on What's Next for Greece's Debt Woes

Dow Drops Over 100 Points on Trade War Worries

Dow Drops Over 100 Points on Trade War Worries